Scholarlink

<p>This study aims to investigate if there is a difference in the safety and efficacy of catheter ablation of atrial fibrillation (AF) between patients with bioprosthetic mitral valve replacement (MVR) and those with mechanical MVR. A total of 23,794 patients who underwent the first-time catheter ablation of AF were screened. Patients with a history of surgical AF ablation, left atrial appendage closure, or resection were excluded from the study. There were 21 patients in the bioprosthetic MVR group and 85 patients in the mechanical MVR group were included in the study. After a median follow-up of 17.9 (14.4, 21.4) months, AF recurrence rates were similar between the two groups (52.4% vs. 50.6%, log-rank <i>p</i> = 0.527). Persistent AF was independently associated with AF recurrence (HR 1.83, [95% CI 1.00–3.33], <i>p</i> &lt; 0.05). Mitral isthmus block rates were 78.6% in the bioprosthetic MVR group and 69.6% in the mechanical MVR group (<i>p</i> = 0.508). No instances of catheter entrapment were reported in this study. Two pseudoaneurysm and one acute cerebral infarction occurred in the mechanical MVR group. The safety and effectiveness of AF catheter ablation were comparable between patients with mechanical MVR and those with bioprosthetic MVR.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Safety and effectiveness of catheter ablation of atrial fibrillation in patients with mitral valve replacement mechanical versus bioprosthetic valves

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2025年10月1日

查看全文
  • Xiao-Ying Liu,
  • De-Yong Long,
  • Jian-Zeng Dong,
  • Xin Du,
  • Cai-Hua Sang,
  • Rong-Hui Yu,
  • Chen-Xi Jiang,
  • Nian Liu,
  • Song-Nan Li,
  • Wei Wang,
  • Xue-Yuan Guo,
  • Xin Zhao,
  • Chang-Yi Li,
  • Song Zuo,
  • Meng-Meng Li,
  • Chang-Qi Jia,
  • Yue-Xin Jiang,
  • Wen-He Lv,
  • Ze-Yang Wu,
  • Yu-Kun Li,
  • Xue-Si Wang,
  • Zhuo-Hang Du,
  • Ri-Bo Tang,
  • Chang-Sheng Ma

摘要

This study aims to investigate if there is a difference in the safety and efficacy of catheter ablation of atrial fibrillation (AF) between patients with bioprosthetic mitral valve replacement (MVR) and those with mechanical MVR. A total of 23,794 patients who underwent the first-time catheter ablation of AF were screened. Patients with a history of surgical AF ablation, left atrial appendage closure, or resection were excluded from the study. There were 21 patients in the bioprosthetic MVR group and 85 patients in the mechanical MVR group were included in the study. After a median follow-up of 17.9 (14.4, 21.4) months, AF recurrence rates were similar between the two groups (52.4% vs. 50.6%, log-rank p = 0.527). Persistent AF was independently associated with AF recurrence (HR 1.83, [95% CI 1.00–3.33], p < 0.05). Mitral isthmus block rates were 78.6% in the bioprosthetic MVR group and 69.6% in the mechanical MVR group (p = 0.508). No instances of catheter entrapment were reported in this study. Two pseudoaneurysm and one acute cerebral infarction occurred in the mechanical MVR group. The safety and effectiveness of AF catheter ablation were comparable between patients with mechanical MVR and those with bioprosthetic MVR.